Hjem › Merkelcellecarcinom › New York
Merkelcellecarcinom kliniske forsøg i New York
4 studier for Merkelcellecarcinom søger deltagere på steder i New York.
Byer i New York
Officiel studietekst (engelsk)
Phase II Study of Peptide Receptor Radionuclide Therapy in Combination With Immunotherapy for Patients With Merkel Cell Cancer
- Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 25. sep. 2026 · NCT05583708A Study of CRD3874-SI in People With Solid Tumors
- Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- og 1 flere
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT06021626Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- NYU Langone Hospital - Long Island, Mineola
- Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 31. aug. 2026 · NCT05896839A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 12. aug. 2026 · NCT05859074Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.